Category Archives: Science

Science Press Releases & News distributed via EuropaWire

AFFECT-EU Urges Routine Atrial Fibrillation Screening for At-Risk Patients

(IN BRIEF) The AFFECT-EU project, culminating in its final event in Brussels, recommends routine atrial fibrillation (AF) screening for individuals at risk, emphasizing its potential to prevent strokes and improve outcomes. Led by Professor Renate Schnabel, the project advocates for … Read the full press release

CHIL Receives £4.9m Investment to Spearhead Healthcare Advancements through Data Science

(IN BRIEF) The University of Liverpool’s Civic Health Innovation Labs (CHIL) has secured a substantial £4.9 million investment from the Office for Life Sciences (OLS) to drive healthcare improvements via data science. Through the ‘Data-Action Accelerator’ project, CHIL aims to … Read the full press release

Dutch Government Funds Interdisciplinary Projects for Mission-Driven Innovation Acceleration

(IN BRIEF) The Dutch government has allocated funding to three interdisciplinary projects under the KIC Mission call ‘Realisation, acceleration and upscaling of mission-driven innovation’. These projects, part of the KIA Societal Earning Capacity, aim to address major societal challenges such … Read the full press release

University of Exeter Academics Honored with NIHR Senior Investigator Status for Outstanding Research Contributions

(IN BRIEF) Two esteemed academics at the University of Exeter, Professor Vicki Goodwin MBE and Professor G.J. Melendez-Torres, have been granted the prestigious National Institute for Health and Care Research (NIHR) Senior Investigator status, underscoring their exceptional research endeavors. Their … Read the full press release

EHRA 2024: Unveiling Groundbreaking Innovations in Arrhythmia Management

(IN BRIEF) Prepare for the latest advancements in the prevention and treatment of heart rhythm disorders at EHRA 2024, the annual congress of the European Heart Rhythm Association (EHRA), part of the European Society of Cardiology (ESC). Set to take … Read the full press release

EQT Life Sciences Portfolio Company Amolyt Pharma Acquired by Alexion, AstraZeneca Rare Diseases for $1.05 Billion

(IN BRIEF) EQT Life Sciences announces the acquisition of its portfolio company, Amolyt Pharma, by Alexion, AstraZeneca Rare Diseases, for a total deal value of $1.05 billion. This acquisition underscores Amolyt’s significant advancements in developing novel treatments for rare endocrine … Read the full press release

Evonik Vland Biotech Launches Joint Venture to Enhance Animal Gut Health Solutions

(IN BRIEF) The joint venture, Evonik Vland Biotech, established by Evonik China and Shandong Vland Biotech, officially commenced operations in Binzhou, China, aiming to bolster the market presence of probiotics for livestock gut health in the Greater China region while … Read the full press release

Evonik’s EUDRAGIT® Polymers: Pioneering Pharmaceutical Innovation for 70 Years

(IN BRIEF) Evonik’s EUDRAGIT® polymers, renowned coatings for pharmaceuticals, celebrate 70 years of revolutionizing drug delivery. With over 23,000 patents and 10,000 scientific publications, these methacrylate polymers have become industry standards, employed in formulations for modified drug release across 80 … Read the full press release

Tubulis Secures €128 Million Series B2 Financing to Advance Novel ADC Pipeline for Cancer Treatment

(IN BRIEF) Tubulis has closed an oversubscribed €128 million ($138.8 million) Series B2 financing round, co-led by EQT Life Sciences and Nextech Invest Ltd, with participation from new and existing investors including Frazier Life Sciences and Deep Track Capital. The … Read the full press release

TUM’s Vital Role in Quantum Satellite Initiative: A Secure Frontier Unveiled

(IN BRIEF) As the threat of quantum computers grows, rendering traditional encryption methods obsolete, researchers at the Technical University of Munich (TUM) are pioneering a new approach. Led by Professor Tobias Vogl, they’re developing quantum encryption based on the immutable … Read the full press release

Agfa Appoints Jeroen Spruyt as President of Radiology Solutions Division

(IN BRIEF) Effective March 13, 2024, Jeroen Spruyt is appointed as President of Agfa’s Radiology Solutions division and joins the company’s Executive Management Team. With a background in Applied Economics and an MBA from Vlerick Business School, Spruyt brings extensive … Read the full press release

Heatwaves Threaten Tsetse Fly Fertility, Raising Concerns for Disease Spread

(IN BRIEF) A groundbreaking study conducted by researchers from the University of Bristol and Stellenbosch University reveals that a single burst of hot weather significantly impacts the fertility of both female and male tsetse flies, key vectors for diseases like … Read the full press release

University of Bristol Secures £57 Million Funding Boost for Cutting-Edge Research Centers

(IN BRIEF) The University of Bristol has received a substantial £57 million funding injection from UK Research and Innovation (UKRI) and its Engineering and Physical Sciences Research Council (EPSRC) to establish nine Centres for Doctoral Training (CDTs). These centers will … Read the full press release

Harnessing AI for Enhanced Marine Data Collection: A Step Towards Ocean Conservation

(IN BRIEF) Researchers from the University of Helsinki, in collaboration with partners from the University of Tartu, University of Madeira, and MARE-Madeira, ARDITI, are pioneering the integration of Artificial Intelligence (AI) and sensor technologies to revolutionize marine data collection. By … Read the full press release

Isobionics® Unveils Innovative Natural Flavor, beta-Caryophyllene 80, at FlavourTalk Exhibition

(IN BRIEF) Isobionics®, a BASF Aroma Ingredients brand, introduces its latest natural flavor, beta-Caryophyllene 80, at the FlavourTalk Raw Materials Exhibition 2024. Developed to meet specific customer requirements, this flavor expands Isobionics®’ portfolio beyond citrus products. Made using cutting-edge biotechnology, … Read the full press release

Evonik Launches Skin Institute to Revolutionize Cosmetics with Science-Backed Solutions

(IN BRIEF) Evonik introduces the Evonik Skin Institute, a global network of life science experts and labs aimed at bolstering support for claim-substantiated cosmetics. This initiative merges Evonik’s advanced biotech platform with a global network of evaluation labs, enhancing customer … Read the full press release

Health Canada Authorizes Probiotic Strain CLEPIUS™ for Alleviating Digestive Discomfort and Stress

(IN BRIEF) Health Canada has approved functional claims for Novonesis’ probiotic strain CLEPIUS™, acknowledging its efficacy in alleviating symptoms of irritable bowel syndrome (IBS) and improving quality of life in adults. The authorization encompasses a range of benefits, including relief … Read the full press release

Breakthrough Study Shows Amlitelimab’s Long-lasting Effectiveness in Atopic Dermatitis Treatment

(IN BRIEF) In a groundbreaking Phase 2b study, amlitelimab demonstrates remarkable potential in maintaining treatment response for patients with moderate to severe atopic dermatitis (AD). Presented at the American Academy of Dermatology (AAD) 2024 Conference, the study reveals sustained improvement … Read the full press release

Basilea Pharmaceutica Celebrates Milestone Payment as Cresemba® Sales Soar in Asia Pacific and China

(IN BRIEF) Basilea Pharmaceutica Ltd (SIX: BSLN) announced a significant milestone with a USD 1.25 million payment triggered by the robust sales performance of its antifungal medication, Cresemba® (isavuconazole), in the Asia Pacific region and China by its license partner … Read the full press release

Boehringer Ingelheim and Sosei Heptares Forge Global Collaboration to Pioneer Precision Treatment for Schizophrenia

(IN BRIEF) Boehringer Ingelheim and Sosei Group Corporation (Sosei Heptares) have unveiled a global collaboration and exclusive option-to-license agreement aimed at advancing the development and commercialization of Sosei Heptares’ portfolio of first-in-class GPR52 agonists. The focus of this collaboration lies … Read the full press release

Innovative Oral Contraception Program Targets Growing Wild Boar Issue

(IN BRIEF) Researchers are launching a pioneering initiative to address the surging wild boar population across parts of Europe by administering oral contraception to the animals. With numbers of wild boar escalating rapidly and posing significant economic and environmental threats, … Read the full press release

Thales Alenia Space Selected for Mars Ice Mapper Communications Development

(IN BRIEF) Thales Alenia Space has been contracted by the Italian Space Agency (ASI) to develop the communications subsystem for the International Mars Ice Mapper (I-MIM) mission. The mission aims to identify and measure water ice on Mars. Thales Alenia … Read the full press release

GSK Reports Positive Results from DREAMM-8 Phase III Trial of Blenrep in Multiple Myeloma Treatment

(IN BRIEF) GSK has announced encouraging findings from the interim analysis of the DREAMM-8 phase III trial evaluating Blenrep (belantamab mafodotin) in combination with pomalidomide plus dexamethasone (PomDex) compared to the standard of care, bortezomib plus PomDex, for relapsed or … Read the full press release

Novo Nordisk Hosts Capital Markets Day to Share Progress on Strategic Aspirations 2025

(IN BRIEF) Novo Nordisk is conducting a Capital Markets Day (CMD) to provide updates on its Strategic Aspirations 2025. The event will focus on various aspects, including corporate strategy, sustainability, research and development pipeline, and financial performance. Highlights include discussions … Read the full press release

Philips Tops Clarivate’s 2024 Global Innovator List for 11th Consecutive Year

(IN BRIEF) Royal Philips, a prominent figure in health technology, has once again secured its position in the 2024 Clarivate Top 100 Global Innovator™ list, marking its eleventh consecutive inclusion. With a dedication to R&D programs and collaborative efforts, Philips … Read the full press release

Biotech Acceleration: Evotec and Claris Ventures Unite to Propel Portfolio Companies Forward

(IN BRIEF) Evotec and Claris Ventures have formed a strategic partnership to accelerate the progress of biotech ventures in Claris’s portfolio into clinical trials. This collaboration allows Claris’s portfolio companies, focused on biotech ventures nearing clinical trials, streamlined access to … Read the full press release

Novo Nordisk’s Semaglutide Shows Promise in Kidney Outcomes Trial FLOW

(IN BRIEF) Novo Nordisk has announced promising headline results from the kidney outcomes trial FLOW, which compared injectable semaglutide 1.0 mg with placebo as an adjunct to standard care for people with type 2 diabetes and chronic kidney disease (CKD). … Read the full press release

What’s new in cancer care across Europe in early 2024 (1 Jan – 5 Mar 2024): Advancements, Innovations, Research, Awareness

(IN BRIEF) In early 2024, Europe’s medical and research communities announced major breakthroughs in cancer care, highlighting new treatments like AstraZeneca and Daiichi Sankyo’s datopotamab deruxtecan for lung and breast cancer, and AstraZeneca’s Tagrisso for EGFR-mutated lung cancer. Diagnostic advancements … Read the full press release

Phagenesis Secures $42M Investment Led by EQT Life Sciences to Revolutionize Swallowing Disorder Treatment

(IN BRIEF) Phagenesis, a UK-based medical technology company specializing in treating swallowing disorders, has closed a significant $42 million Series D financing round led by EQT Life Sciences, with co-leadership from Sectoral Asset Management. This substantial investment reflects confidence in … Read the full press release

SGS Launches Comprehensive Solution for MoCRA Compliance

(IN BRIEF) SGS has introduced a comprehensive solution to support organizations in complying with the Modernization of Cosmetics Regulation Act (MoCRA) in the United States. MoCRA, which expands the FDA’s authority over cosmetic products, imposes new requirements on manufacturers and … Read the full press release

EMA Validates Marketing Authorisation Applications for AstraZeneca and Daiichi Sankyo’s Datopotamab Deruxtecan in Lung and Breast Cancer Treatment

(IN BRIEF) The European Medicines Agency (EMA) has validated two marketing authorisation applications (MAAs) for datopotamab deruxtecan (Dato-DXd), developed by AstraZeneca and Daiichi Sankyo, for the treatment of nonsquamous non-small cell lung cancer (NSCLC) and hormone receptor (HR)-positive, HER2-negative breast … Read the full press release

Empathetic Communication Found Effective in Addressing Vaccine Hesitancy, Study Shows

(IN BRIEF) A groundbreaking international study led by the University of Bristol reveals the effectiveness of empathetic correction of misinformation in improving attitudes towards vaccination, particularly among vaccine-hesitant individuals. The research, published in Health Psychology, highlights the significance of empathetic … Read the full press release

Genetic Study Reveals Potential for Tailored Breast Cancer Screening

(IN BRIEF) A recent genetic study conducted by researchers at the University of Helsinki suggests that genetic risk information could revolutionize breast cancer screening, potentially benefiting one in ten women. The study indicates that a comprehensive genetic risk profile could … Read the full press release

Novartis Unveils Promising Results from SMART Study: Zolgensma’s Efficacy Confirmed in Older and Heavier SMA Patients

(IN BRIEF) Novartis has presented compelling data from the SMART study, reinforcing the clinical advantages of Zolgensma® (onasemnogene abeparvovec) in treating spinal muscular atrophy (SMA) patients weighing ≥ 8.5 kg to ≤ 21 kg, with a mean age of 4.69 … Read the full press release

Global Warming Amplifies Risks: UEA-Led Study Warns of Heightened Climate Threats to Developing Countries

(IN BRIEF) A research program led by the University of East Anglia (UEA) has quantified how climate change risks increase at a national scale with rising global temperatures. Focusing on six countries including Brazil, China, Egypt, Ethiopia, Ghana, and India, … Read the full press release

Sustainable Support: Repsol Powers Spanish Antarctic Campaign with 100% Renewable Energy

(IN BRIEF) Repsol, a leading energy company, is supplying 100% renewable fuels to power the Gabriel de Castilla Base during the Spanish Army’s 37th Antarctic Campaign. This initiative supports sustainability efforts in one of the most environmentally sensitive regions on … Read the full press release

Driving Environmental Excellence: Metso Elevates Emission Reduction Efforts with Cutting-Edge Scrubber Pilot Plant

(IN BRIEF) Metso has installed a state-of-the-art multi-purpose scrubber pilot plant at its R&D center in Frankfurt, Germany. This facility will focus on developing and optimizing gas cleaning processes, particularly simultaneous scrubbing of SO2 and NOx at low temperatures. Equipped … Read the full press release

Voydeya Recommended for EU Marketing Authorization as PNH Treatment Add-On

(IN BRIEF) Voydeya (danicopan), a first-in-class oral Factor D inhibitor, has been recommended for marketing authorization in the European Union (EU) as an add-on to ravulizumab or eculizumab for adult patients with paroxysmal nocturnal haemoglobinuria (PNH) who experience residual haemolytic … Read the full press release

GSK’s Gepotidacin Shows Promise as Gonorrhoea Treatment: Positive Results from EAGLE-1 Trial

(IN BRIEF) GSK plc has announced positive headline results from the pivotal EAGLE-1 phase III trial for gepotidacin, an oral antibiotic aimed at treating uncomplicated urogenital gonorrhoea in adolescents and adults. The trial demonstrated gepotidacin’s non-inferiority compared to the current … Read the full press release

Boehringer Ingelheim’s Survodutide Shows Promising Results as Potential Best-in-Class Treatment for MASH in Phase II Trial

(IN BRIEF) Boehringer Ingelheim has reported compelling results from its Phase II trial of Survodutide, a novel glucagon/GLP-1 receptor dual agonist, indicating its potential to become a leading treatment for Metabolic Dysfunction-Associated Steatohepatitis (MASH). In the trial, up to 83.0% … Read the full press release